药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Apraclonidine
Tocopherylquinone
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Tocopherylquinone.
Apraclonidine
(S)-Warfarin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with (S)-Warfarin.
Apraclonidine
Saruplase
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Saruplase.
Apraclonidine
Melagatran
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Melagatran.
Apraclonidine
Tioclomarol
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Tioclomarol.
Apraclonidine
Diphenadione
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Diphenadione.
Apraclonidine
Clorindione
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Clorindione.
Apraclonidine
Brinase
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Brinase.
Apraclonidine
Protein S human
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Protein S human.
Apraclonidine
Fluindione
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Fluindione.
Apraclonidine
Gabexate
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Gabexate.
Apraclonidine
Nafamostat
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Nafamostat.
Apraclonidine
Betrixaban
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Betrixaban.
Apraclonidine
Darexaban
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Darexaban.
Apraclonidine
Letaxaban
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Letaxaban.
Apraclonidine
Antithrombin III human
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Antithrombin III human.
Apraclonidine
Protein C
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Protein C.
Apraclonidine
Antithrombin Alfa
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Antithrombin Alfa.
Apraclonidine
Zinc citrate
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Zinc citrate.
Apraclonidine
Desirudin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Desirudin.